American Industry and the U.S. Cardiovascular Clinical Research Enterprise

The report by Kim et al. ([1][1]) in this issue of the Journal documents the increasingly widespread phenomenon of the “offshoring” of clinical research—in this case, clinical trials conducted in foreign countries despite being funded by U.S. taxpayers, administered through grants...